At first, the monovalent influenza A (H5N8) vaccine will be tested in two doses, 21 days apart, in adults aged 18–59.

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...

The so-called "big, beautiful bill" will lead to millions of fewer people having health coverage in the United States. It will make the country less prepared to detect and respond to a future pandemic ...

HHS Secretary Robert F. Kennedy Jr. and Secretary of Agriculture Brooke Rollins have expressed interest in letting H5N1 ...

Biosafety level (BSL)-3 facilities exist in a diffuse regulatory environment, where requirements depend on factors such as the kinds of pathogens under study, the type of research being conducted, and ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

The University of Minnesota is stepping up efforts to identify biological threats that could trigger an epidemic, launching ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

At top AI labs, the future looks either fantastically bright—or terrifyingly dark. More in today’s TIME tech newsletter.

Bird flu continues to spread quickly through the U.S. farm system because that system is inherently a viral playground.